Memantine attenuates delayed vasospasm after experimental subarachnoid hemorrhage via modulating endothelial nitric oxide synthase

International Journal of Molecular Sciences

Volumn 16, Issue 6, 2015, Pages 14171-14180

  Huang, Chih Yuan ^a,b   Wang, Liang Chao ^a,b   Shan, Yan Shen ^a,b   Pan, Chia Hsin ^a   Tsai, Kuen Jer ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Memantine; Nitric oxide synthase; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MEMANTINE; AMINO ACID RECEPTOR BLOCKING AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BASILAR ARTERY; BRAIN VASOSPASM; CONTROLLED STUDY; DELAYED VASOSPASM; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SUBARACHNOID HEMORRHAGE; UPREGULATION; WESTERN BLOTTING; ANIMAL; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM; VASOSPASM, INTRACRANIAL;

RATTUS;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MEMANTINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 84934970923     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160614171     Document Type: Article

References (35)

1. Macdonald, R.L.; Cusimano, M.D.; Etminan, N.; Hanggi, D.; Hasan, D.; Ilodigwe, D.; Jaja, B.; Lantigua, H.; Le Roux, P.; Lo, B.; et al. Subarachnoid hemorrhage international trialists data repository (SAHIT). World Neurosurg. 2013, 79, 418–422.
2. King, J.T., Epidemiology of aneurysmal subarachnoid hemorrhage. Neuroimaging Clin. N. Am. 1997, 7, 659–668.
3. Forstermann, U.; Munzel, T. Endothelial nitric oxide synthase in vascular disease: From marvel to menace. Circulation 2006, 113, 1708–1714.
4. Garland, C.J.; Hiley, C.R.; Dora, K.A. EDHF: Spreading the influence of the endothelium. Br. J. Pharmacol. 2011, 164, 839–852.
5. Van Faassen, E.E.; Bahrami, S.; Feelisch, M.; Hogg, N.; Kelm, M.; Kim-Shapiro, D.B.; Kozlov, A.V.; Li, H.; Lundberg, J.O.; Mason, R.; et al. Nitrite as regulator of hypoxic signaling in mammalian physiology. Med. Res. Rev. 2009, 29, 683–741.
6. Sehba, F.A.; Chereshnev, I.; Maayani, S.; Friedrich, V.,; Bederson, J.B. Nitric oxide synthase in acute alteration of nitric oxide levels after subarachnoid hemorrhage. Neurosurgery 2004, 55, 671–678.
7. Pluta, R.M.; Oldfield, E.H. Analysis of nitric oxide (NO) in cerebral vasospasm after aneursymal bleeding. Rev. Recent Clin. Trials 2007, 2, 59–67.
8. Sabri, M.; Ai, J.; Knight, B.; Tariq, A.; Jeon, H.; Shang, X.; Marsden, P.A.; Loch Macdonald, R. Uncoupling of endothelial nitric oxide synthase after experimental subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 2011, 31, 190–199.
9. Sabri, M.; Ai, J.; Lass, E.; D’Abbondanza, J.; Macdonald, R.L. Genetic elimination of eNOS reduces secondary complications of experimental subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 2013, 33, 1008–1014.
10. Lipton, S.A. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRX 2004, 1, 101–110.
11. Huang, C.Y.; Wang, L.C.; Wang, H.K.; Pan, C.H.; Cheng, Y.Y.; Shan, Y.S.; Chio, C.C.; Tsai, K.J. Memantine alleviates brain injury and neurobehavioral deficits after experimental subarachnoid hemorrhage. Mol. Neurobiol. 2014, 51, 1038–1052.
12. Bederson, J.B.; Germano, I.M.; Guarino, L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke 1995, 26, 1086–1092.
13. Jeon, H.; Ai, J.; Sabri, M.; Tariq, A.; Shang, X.; Chen, G.; Macdonald, R.L. Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage. BMC Neurosci. 2009, 10, 103.
14. Gules, I.; Satoh, M.; Clower, B.R.; Nanda, A.; Zhang, J.H. Comparison of three rat models of cerebral vasospasm. Am. J. Physiol. Heart Circ. Physiol. 2002, 283, H2551–H2559.
15. Rammes, G.; Danysz, W.; Parsons, C.G. Pharmacodynamics of memantine: An update. Curr. Neuropharmacol. 2008, 6, 55–78.
16. Chen, H.S.; Wang, Y.F.; Rayudu, P.V.; Edgecomb, P.; Neill, J.C.; Segal, M.M.; Lipton, S.A.; Jensen, F.E. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience 1998, 86, 1121–1132.
17. Sharp, C.D.; Houghton, J.; Elrod, J.W.; Warren, A.; Jackson, T.H.,; Jawahar, A.; Nanda, A.; Minagar, A.; Alexander, J.S. N-methyl-D-aspartate receptor activation in human cerebral endothelium promotes intracellular oxidant stress. Am. J. Physiol. Heart Circ. Physiol. 2005, 288, H1893–H1899.
18. Sharp, C.D.; Hines, I.; Houghton, J.; Warren, A.; Jackson, T.H., IV; Jawahar, A.; Nanda, A.; Elrod, J.W.; Long, A.; Chi, A.; et al. Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am. J. Physiol. Heart Circ. Physiol. 2003, 285, H2592–H2598.
19. Schulz, M.K.; Wang, L.P.; Tange, M.; Bjerre, P. Cerebral microdialysis monitoring: Determination of normal and ischemic cerebral metabolisms in patients with aneurysmal subarachnoid hemorrhage. J. Neurosurg. 2000, 93, 808–814.
20. Germano, A.; Caffo, M.; Angileri, F.F.; Arcadi, F.; Newcomb-Fernandez, J.; Caruso, G.; Meli, F.; Pineda, J.A.; Lewis, S.B.; Wang, K.K.; et al. NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat. J. Neurotrauma 2007, 24, 732–744.
21. Germano, A.; d’Avella, D.; Imperatore, C.; Caruso, G.; Tomasello, F. Time-course of blood-brain barrier permeability changes after experimental subarachnoid haemorrhage. Acta Neurochir. 2000, 142, 575–581.
22. Park, S.; Yamaguchi, M.; Zhou, C.; Calvert, J.W.; Tang, J.; Zhang, J.H. Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke 2004, 35, 2412–2417.
23. Kozniewska, E.; Michalik, R.; Rafalowska, J.; Gadamski, R.; Walski, M.; Frontczak-Baniewicz, M.; Piotrowski, P.; Czernicki, Z. Mechanisms of vascular dysfunction after subarachnoid hemorrhage. J. Physiol. Pharmacol. 2006, 57, 145–160.
24. Doczi, T.P.; Joo, F.; Balas, I. Atrial natriuretic peptide (ANP) attenuates brain oedema accompanying experimental subarachnoid haemorrhage. Acta Neurochir. 1995, 132, 87–91.
25. Zuccarello, M.; Lewis, A.I.; Upputuri, S.; Farmer, J.B.; Anderson, D.K. Effect of remacemide hydrochloride on subarachnoid hemorrhage-induced vasospasm in rabbits. J. Neurotrauma 1994, 11, 691–698.
26. Sabri, M.; Ai, J.; Marsden, P.A.; Macdonald, R.L. Simvastatin re-couples dysfunctional endothelial nitric oxide synthase in experimental subarachnoid hemorrhage. PLoS ONE 2011, 6, e17062.
27. Santhanam, A.V.; Smith, L.A.; Akiyama, M.; Rosales, A.G.; Bailey, K.R.; Katusic, Z.S. Role of endothelial NO synthase phosphorylation in cerebrovascular protective effect of recombinant erythropoietin during subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 2005, 36, 2731–2737.
28. Dorhout Mees, S.M.; Rinkel, G.J.; Feigin, V.L.; Algra, A.; van den Bergh, W.M.; Vermeulen, M.; van Gijn, J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst. Rev. 2007, doi:10.1002/14651858.CD000277.pub3.
29. Kronvall, E.; Undren, P.; Romner, B.; Saveland, H.; Cronqvist, M.; Nilsson, O.G. Nimodipine in aneurysmal subarachnoid hemorrhage: A randomized study of intravenous or peroral administration. J. Neurosurg. 2009, 11 0, 58–63.
30. Dumont, A.S.; Dumont, R.J.; Chow, M.M.; Lin, C.L.; Calisaneller, T.; Ley, K.F.; Kassell, N.F.; Lee, K.S. Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation. Neurosurgery 2003, 53, 123–135.
31. Miller, B.A.; Turan, N.; Chau, M.; Pradilla, G. Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage. BioMed Res. Int. 2014, 2014, 384342.
32. Gatti, S.; Lonati, C.; Acerbi, F.; Sordi, A.; Leonardi, P.; Carlin, A.; Gaini, S.M.; Catania, A. Protective action of NDP-MSH in experimental subarachnoid hemorrhage. Exp. Neurol. 2012, 234, 230–238.
33. Giuliani, D.; Mioni, C.; Altavilla, D.; Leone, S.; Bazzani, C.; Minutoli, L.; Bitto, A.; Cainazzo, M.M.; Marini, H.; Zaffe, D.; et al. Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology 2006, 147, 1126–1135.
34. Ottani, A.; Giuliani, D.; Mioni, C.; Galantucci, M.; Minutoli, L.; Bitto, A.; Altavilla, D.; Zaffe, D.; Botticelli, A.R.; Squadrito, F.; et al. Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke. J. Cereb. Blood Flow Metab. 2009, 29, 512–523.
35. Tsai, K.J.; Yang, C.H.; Fang, Y.H.; Cho, K.H.; Chien, W.L.; Wang, W.T.; Wu, T.W.; Lin, C.P.; Fu, W.M.; Shen, C.K. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J. Exp. Med. 2010, 207, 1661–1673.